118 related articles for article (PubMed ID: 33682591)
21. Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Stein EM; DiNardo CD; Fathi AT; Mims AS; Pratz KW; Savona MR; Stein AS; Stone RM; Winer ES; Seet CS; Döhner H; Pollyea DA; McCloskey JK; Odenike O; Löwenberg B; Ossenkoppele GJ; Patel PA; Roshal M; Frattini MG; Lersch F; Franovic A; Nabhan S; Fan B; Choe S; Wang H; Wu B; Hua L; Almon C; Cooper M; Kantarjian HM; Tallman MS
Blood; 2021 Apr; 137(13):1792-1803. PubMed ID: 33024987
[TBL] [Abstract][Full Text] [Related]
22. Congenital leukemia cutis presenting as multiple violaceous lesions in a newborn.
Jandali S; Kirschner RE
Ann Plast Surg; 2011 Mar; 66(3):310-2. PubMed ID: 21233703
[TBL] [Abstract][Full Text] [Related]
23. Thyroiditis: A Rare Manifestation of Enasidenib-Induced Differentiation Syndrome.
Annamaraju P; Gopishetty S; Goparaju N; Beasey M; Kota V; Guddati AK
Case Rep Oncol; 2020; 13(2):583-587. PubMed ID: 32547385
[TBL] [Abstract][Full Text] [Related]
24. Leukemic infiltrate appearing as periorbital cellulitis.
Grossniklaus HE; Wojno TH
Arch Ophthalmol; 1990 Apr; 108(4):484. PubMed ID: 2322149
[No Abstract] [Full Text] [Related]
25. Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.
Norsworthy KJ; Mulkey F; Scott EC; Ward AF; Przepiorka D; Charlab R; Dorff SE; Deisseroth A; Kazandjian D; Sridhara R; Beaver JA; Farrell AT; de Claro RA; Pazdur R
Clin Cancer Res; 2020 Aug; 26(16):4280-4288. PubMed ID: 32393603
[TBL] [Abstract][Full Text] [Related]
26. IDH Inhibitors in AML-Promise and Pitfalls.
McMurry H; Fletcher L; Traer E
Curr Hematol Malig Rep; 2021 Apr; 16(2):207-217. PubMed ID: 33939107
[TBL] [Abstract][Full Text] [Related]
27. Concurrent chronic lymphocytic leukemia cutis and acute myelogenous leukemia cutis in a patient with untreated CLL.
Miller MK; Strauchen JA; Nichols KT; Phelps RG
Am J Dermatopathol; 2001 Aug; 23(4):334-40. PubMed ID: 11481527
[TBL] [Abstract][Full Text] [Related]
28. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis.
Pina-Oviedo S; Torres-Cabala CA; Miranda RN; Tetzlaff MT; Singh S; Rapini RP; Prieto VG; Aung PP
Am J Dermatopathol; 2017 May; 39(5):388-392. PubMed ID: 27759701
[TBL] [Abstract][Full Text] [Related]
29. Neutrophilic eccrine hidradenitis masquerading as facial cellulitis.
Srivastava M; Scharf S; Meehan SA; Polsky D
J Am Acad Dermatol; 2007 Apr; 56(4):693-6. PubMed ID: 17109994
[TBL] [Abstract][Full Text] [Related]
30. Dose-related periorbital edema following sorafenib in a patient with acute myeloid leukemia.
Freyer CW; Mangan JK
J Oncol Pharm Pract; 2019 Dec; 25(8):2035-2037. PubMed ID: 30537918
[TBL] [Abstract][Full Text] [Related]
31. Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatment.
Reed DR; Elsarrag RZ; Morris AL; Keng MK
Cancer Manag Res; 2019; 11():8073-8080. PubMed ID: 31564968
[TBL] [Abstract][Full Text] [Related]
32. Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical Models.
Thomas D; Majeti R
Cancer Discov; 2017 May; 7(5):459-461. PubMed ID: 28461409
[TBL] [Abstract][Full Text] [Related]
33. Erythema nodosum after azacitidine in a patient with acute myeloid leukemia.
Nasrollahi E; Giubellino A; Rashidi A
J Oncol Pharm Pract; 2023 Jan; 29(1):226-229. PubMed ID: 35503303
[TBL] [Abstract][Full Text] [Related]
34. Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy.
Galkin M; Jonas BA
Core Evid; 2019; 14():3-17. PubMed ID: 31118877
[No Abstract] [Full Text] [Related]
35. Sweet's syndrome masquerading as facial cellulitis.
Crum NF; Higginbottom PA; Fehl FC; Graham BS
Cutis; 2003 Jun; 71(6):469-72. PubMed ID: 12839258
[TBL] [Abstract][Full Text] [Related]
36. Periorbital cellulitis.
Jackson K; Baker SR
Head Neck Surg; 1987; 9(4):227-34. PubMed ID: 3312114
[TBL] [Abstract][Full Text] [Related]
37. A case of aleukemic leukemia cutis after COVID-19 infection presenting as facial rash.
Shen NW; Freitas CP; Bacchi CE; Gru AA
J Cutan Pathol; 2023 Jul; 50(7):606-610. PubMed ID: 37069795
[TBL] [Abstract][Full Text] [Related]
38. Leukemia cutis as the presenting symptom of acute myeloid leukemia: report of three cases.
Moyer AB; Rembold J; Lee NE; Johnson G; Gardner JM
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142735
[TBL] [Abstract][Full Text] [Related]
39. CT demonstration of periorbital graft-versus-host disease.
Cole JW; Quint DJ; Hutchinson RJ; Yanik GA
AJNR Am J Neuroradiol; 1997 Apr; 18(4):730-2. PubMed ID: 9127039
[TBL] [Abstract][Full Text] [Related]
40. Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia.
Wang CX; Pusic I; Anadkat MJ
JAMA Dermatol; 2019 Jul; 155(7):826-832. PubMed ID: 30969325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
